Aurobindo Pharma receives USFDA approval for amoxicillin

The US Food and Drug Administration (USFDA) has granted final approval for the Hyderabad-based Aurobindo Pharma Limited to manufacture and market amoxicilin for oral suspension. This Abbreviated New Drug Application (ANDA) was approved out of unit 12, semi-synthetic Penicillin facility in Hyderabad, the company said in a press release. The product has a market size of $ 19 million for the twelve month period ending July 2014, it said quoting the IMS data.
 
This oral suspension is a generic equivalent to the reference listed drug product of Teva Pharmaceutical Industries Limited and indicated in the treatment of certain bacterial infections, according to the release.